Episodic Cluster Headache Completed Phase 3 Trials for Galcanezumab (DB14042)

Also known as: Cluster Headache, Episodic / Episodic cluster headache, not intractable / Episodic cluster headache (disorder) / Chronic cluster headache / Cluster headache syndrome, unspecified / Chronic cluster headache, not intractable / Cluster headache syndrome, unspecified, not intractable / Cluster headaches and other trigeminal autonomic cephalgias (TAC) / Headache histamine / Horton's headache / Headache vasomotor / Migrainous neuralgia / Ciliary neuralgia (finding) / Chronic cluster headache (disorder) / Cluster Headache / Cluster headache syndrome (disorder) / Headaches cluster / Cluster headaches

IndicationStatusPhase
DBCOND0029864 (Episodic Cluster Headache)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02397473
A Study Of Galcanezumab In Participants With Episodic Cluster HeadacheTreatment
NCT02797951
A Study of LY2951742 (Galcanezumab) in Participants With Cluster HeadacheTreatment